Long COVID-19 and Peripheral Serotonin: A Commentary and Reconsideration
Journal of Inflammation Research,
Journal Year:
2024,
Volume and Issue:
Volume 17, P. 2169 - 2172
Published: April 1, 2024
Abstract:
We
believe
there
are
serious
problems
with
a
recently
published
and
highly
publicized
paper
entitled
"Serotonin
reduction
in
post-acute
sequelae
of
viral
infection."
The
blood
centrifugation
procedure
reportedly
used
by
Wong
et
al
would
produce
plasma
that
is
substantially
(over
95%)
depleted
platelets.
Given
this,
their
mean
serotonin
values
1.2
uM
2.4
for
the
control/contrast
groups
appear
to
be
at
least
30
60
times
too
high
should
disregarded.
reported
long
COVID
viremia
patients
also
disregarded,
as
any
comparisons
groups.
note
means
two
not
good
agreement.
In
"Discussion"
section,
state
results
tend
support
use
selective
reuptake
inhibitors
(SSRIs)
treatment
COVID-19,
they
encourage
further
clinical
trials
SSRIs.
While
that,
"Our
animal
models
demonstrate
levels
can
restored
memory
impairment
reversed
precursor
supplementation
or
SSRI
treatment",
it
noted
no
data
presented
showing
an
increase
restoration
circulating
administration.
fact,
one
expect
marked
decline
platelet
due
SSRIs'
effective
inhibition
transporter.
hypothesize
arise
from
little
peripheral
serotonin.
However,
given
frequent
presence
hyperaggregation
COVID,
known
augmenting
effects
on
aggregation,
plausible
suggest
reductions
might
associated
lessening
cardiovascular
COVID-19.
Keywords:
serotonin,
plasma,
platelets,
infection
Language: Английский
Secondary Neutropenias
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(2), P. 497 - 497
Published: Feb. 17, 2025
Neutrophils
are
a
critical
component
of
immunity,
particularly
against
bacteria
and
other
pathogens,
but
also
in
inflammation
tissue
repair.
As
consequence,
individuals
with
neutropenia,
defined
by
reduction
absolute
neutrophil
counts,
exhibit
strong
propensity
to
severe
infections
that
typically
present
muted
symptoms.
Neutropenias
encompass
heterogeneous
set
disorders,
comprising
primary
neutropenias,
which
specific
genes
mutated,
the
more
common
secondary
have
diverse
non-genetic
causes.
These
include
hematological
cancers,
involving
both
direct
effects
cancer
itself
indirect
impacts
via
chemotherapeutic,
biological
agents
cell-based
approaches
used
for
treatment.
Other
significant
causes
neutropenias
non-chemotherapeutic
drugs,
autoimmune
immune
diseases,
nutrient
deficiencies.
collectively
act
impacting
production
bone
marrow
and/or
destruction
throughout
body.
This
review
describes
clinical
manifestations
detailing
their
underlying
management,
discussion
alternative
emerging
therapeutic
approaches.
Language: Английский
Distinguishing Swine Flu (H1N1) from COVID-19: Clinical, Virological, and Immunological Perspectives
Archives of Microbiology & Immunology,
Journal Year:
2023,
Volume and Issue:
07(04)
Published: Jan. 1, 2023
This
article
provides
an
in-depth
examination
on
the
differences
between
influenza
A
strain,
H1N1
(also
called
Swine
Flu)
and
Covid-19
focusing
immune
response
clinical
symptoms.
Flu
symptoms
due
to
H1N1,
were
initially
discovered
in
2009.
variant
of
is
believed
have
emerged
through
reassortment,
a
process
where
resulting
virus
inherits
gene
segments
from
each
its
parental
viruses.
reassortment
event
has
resulted
with
altered
characteristics,
potentially
affecting
level
immunity
humans.
The
this
strain
typically
manifest
1-4
days
after
exposure
include
fever,
cough,
sore
throat,
runny/stuffy
nose,
body
aches,
fatigue,
gastrointestinal
such
as
diarrhea.
transmission
dynamics
new
variant,
including
human-to-human
transmission,
are
still
under
investigation
by
health
authorities.
Individuals
weakened
systems
generally
more
susceptible
severe
illness.
Risk
factors
associated
swine
flu
can
older
adults,
young
children,
pregnant
women,
individuals
obesity.
Historical
variants
flu,
2015
India,
been
significant
case
numbers
deaths,
often
respiratory
failure.
Since
epidemic
SARS-CoV2
early
2020,
several
COVID-19
overlap.
In
article,
we
critically
reviewed
similarities
human.
Language: Английский
Hematological Conditions Associated with COVID-19: Pathophysiology, Clinical Manifestations, and Therapeutic Approaches
European Journal of Medical and Health Research,
Journal Year:
2024,
Volume and Issue:
2(5), P. 27 - 47
Published: Sept. 1, 2024
This
review
highlights
the
significant
impact
of
SARS-CoV-2
on
hematological
system,
revealing
complications
such
as
thrombocytopenia,
coagulopathy,
venous
thromboembolism
(VTE),
and
hemolytic
anemia,
which
contribute
notably
to
morbidity
mortality,
especially
in
critically
ill
patients.
The
underlying
mechanisms
involve
direct
viral
effects,
inflammation,
cytokine
storms,
hypercoagulability.
exacerbation
pre-existing
malignancies
common
occurrence
lymphopenia
further
illustrate
complex
interaction
between
COVID-19
immune
system.
emphasizes
importance
early
recognition
management
for
clinical
practice.
It
discusses
necessity
monitoring
biomarkers
like
D-dimer
platelet
counts,
utilizing
imaging
techniques
detecting
thromboembolic
events,
employing
timely
interventions
with
anticoagulants
immunomodulators.
Tailoring
treatment
individual
patient
needs
involving
a
multidisciplinary
team
are
essential
improving
outcomes,
particularly
also
focuses
need
ongoing
research
understand
precise
these
complications,
explore
genetic
environmental
factors,
assess
long-term
outcomes
affected
examines
emerging
variants
developing
innovative
therapeutic
approaches,
including
personalized
medicine
advanced
therapies,
address
challenges
medical
Language: Английский
Complete Blood Count in Children With COVID-19: A Predictor of Disease Severity
Clinical Pediatrics,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 13, 2024
Blood
count
abnormalities
are
frequent
in
patients
with
severe
COVID-19
disease
and
there
is
still
a
lack
of
information
pediatric
complete
blood
(CBC)
results.
Thus,
this
study
aims
to
correlate
the
CBC
emergency
room
children
between
0
10
years
old
clinical
severity
disease.
A
retrospective
cohort
was
performed
who
collected
at
CBC,
C-reactive
protein
(CRP),
platelet
lymphocyte
ratio
(PLR),
neutrophil
(NLR),
monocyte
(NMR),
(LNR),
(LMR),
(MNR)
(MLR).
In
total,
demographic
data
from
93
median
age
19
months
(0.3-126),
60.2%
males,
were
included.
The
main
changes
atypical
lymphocytes
(51.6%)
eosinopenia
(49.5%).
From
69
hospitalized
children,
21
considered
severe.
There
no
association
age,
gender,
CRP
value
severity.
presence
underlying
five
times
higher
(odds
[OR]
=
5.08)
required
hospitalization
NLR
54%
(OR
1.54)
more
likely
occur.
Eosinopenia
three
inpatients
criteria
3.05).
conclusion,
younger
than
have
room,
mainly
eosinopenia.
comorbidity
or
increases
chance
hospitalization.
addition,
predictor
inpatient
due
COVID-19.
Language: Английский
Strategies to Minimize Virus Transmission During Anesthesia Procedures in COVID-19 Patients
Fihr Chaudhary,
No information about this author
Devendra K. Agrawal
No information about this author
Anesthesia and Critical Care,
Journal Year:
2024,
Volume and Issue:
6(4)
Published: Jan. 1, 2024
Anesthesiologists
and
the
critical
care
team
may
be
at
increased
risk
of
contracting
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2,
COVID-19)
due
to
airway
manipulations
intubations
performed
during
anesthesia
administration
management
patient
undergoing
surgery.
SARS-CoV-2
infections
have
been
reported
among
healthcare
workers.
The
virus
is
transmitted
by
close
personal
contact
aerosols.
During
intubation
other
procedures
involving
airway,
anesthesiologist
especially
susceptible
We
a
systematic
analysis
published
reports
on
potential
effects
COVID-19
surgery
team.
identified
immunomodulatory
general
anesthetics
in
presence
infection
patients.
article
also
provides
discussion
current
medical
highlights
evidence-based
key
points
for
safer
practice
surgeries
both
children
adults,
including
obstetric
how
it
could
affect
pregnant
women
receiving
anesthesia.
With
regional
anesthesia,
manipulation
not
necessary,
workers
patients
are
less
likely
contract
same
infection.
Language: Английский
Predicting Intensive Care Unit Admission in COVID-19-Infected Pregnant Women Using Machine Learning
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(24), P. 7705 - 7705
Published: Dec. 17, 2024
Background:
The
rapid
onset
of
COVID-19
placed
immense
strain
on
many
already
overstretched
healthcare
systems.
unique
physiological
changes
in
pregnancy,
amplified
by
the
complex
effects
pregnant
women,
rendered
prioritization
infected
expectant
mothers
more
challenging.
This
work
aims
to
use
state-of-the-art
machine
learning
techniques
predict
whether
a
COVID-19-infected
woman
will
be
admitted
ICU
(Intensive
Care
Unit).
Methods:
A
retrospective
study
using
data
from
women
one
hospital
Astana
and
Shymkent,
Kazakhstan,
May
July
2021.
developed
platform
implements
compares
performance
eight
binary
classifiers,
including
Gaussian
naïve
Bayes,
K-nearest
neighbors,
logistic
regression
with
L2
regularization,
random
forest,
AdaBoost,
gradient
boosting,
eXtreme
linear
discriminant
analysis.
Results:
Data
1292
were
analyzed.
Of
them,
10.4%
ICU.
Logistic
regularization
achieved
highest
F1-score
during
model
selection
phase
while
achieving
an
AUC
0.84
test
set
evaluation
stage.
Furthermore,
feature
importance
analysis
conducted
calculating
Shapley
Additive
Explanation
values
points
leucocyte
counts,
C-reactive
protein,
pregnancy
week,
eGFR
hemoglobin
as
most
important
features
for
predicting
admission.
Conclusions:
predictive
obtained
here
may
efficient
support
tool
prioritizing
care
clinical
practice.
Language: Английский